Departments of Cardiovascular and Renal Research and.
Cancer and Inflammation, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; and.
J Am Soc Nephrol. 2015 Jan;26(1):95-106. doi: 10.1681/ASN.2013111173. Epub 2014 Jul 24.
The epithelial sodium channel (ENaC) of the kidney is necessary for extracellular volume homeostasis and normal arterial BP. Activity of ENaC is enhanced by proteolytic cleavage of the γ-subunit and putative release of a 43-amino acid inhibitory tract from the γ-subunit ectodomain. We hypothesized that proteolytic processing of γENaC occurs in the human kidney under physiologic conditions and that proteinuria contributes to aberrant proteolytic activation. Here, we used monoclonal antibodies (mAbs) with specificity to the human 43-mer inhibitory tract (N and C termini, mAbinhibit, and mAb4C11) and the neoepitope generated after proteolytic cleavage at the prostasin/kallikrein cleavage site (K181-V182 and mAbprostasin) to examine human nephrectomy specimens. By immunoblotting, kidney cortex homogenate from patients treated with angiotensin II type 1 receptor antagonists (n=6) or angiotensin-converting enzyme inhibitors (n=6) exhibited no significant difference in the amount of full-length or furin-cleaved γENaC or the furin-cleaved-to-full-length ratio of γENaC compared with homogenate from patients on no medication (n=5). Patients treated with diuretics (n=4) displayed higher abundance of full-length and furin-cleaved γENaC, with no significant change in the furin-cleaved-to-full-length γENaC ratio. In patients with proteinuria (n=6), the inhibitory tract was detected only in full-length γENaC by mAbinhibit. Prostasin/kallikrein-cleaved γENaC was detected consistently only in tissue from patients with proteinuria and observed in collecting ducts. In conclusion, human kidney γENaC is subject to proteolytic cleavage, yielding fragments compatible with furin cleavage, and proteinuria is associated with cleavage at the putative prostasin/kallikrein site and removal of the inhibitory tract within γENaC.
肾脏的上皮钠离子通道(ENaC)对于细胞外液容量平衡和正常的动脉血压是必要的。ENaC 的活性通过 γ 亚基的蛋白水解切割增强,并且假定从 γ 亚基细胞外域释放 43 个氨基酸的抑制性片段。我们假设在生理条件下,人肾脏中 γENaC 发生蛋白水解加工,并且蛋白尿导致异常的蛋白水解激活。在这里,我们使用针对人 43 个氨基酸抑制片段(N 和 C 末端,mAbinhibit 和 mAb4C11)和在前列腺素原/激肽裂解位点(K181-V182)的蛋白水解裂解后产生的新表位的单克隆抗体(mAbs)(mAbprostasin)来检查人肾切除术标本。通过免疫印迹,用血管紧张素 II 型 1 受体拮抗剂(n=6)或血管紧张素转换酶抑制剂(n=6)治疗的患者的肾皮质匀浆与未用药物治疗的患者的匀浆相比,全长或弗林切割的 γENaC 的量或 γENaC 的弗林切割与全长之比没有显著差异(n=5)。用利尿剂治疗的患者(n=4)显示全长和弗林切割的 γENaC 的丰度更高,而 γENaC 的弗林切割与全长之比没有显著变化。在蛋白尿患者(n=6)中,仅在用 mAbinhibit 检测全长 γENaC 时才检测到抑制性片段。前列腺素原/激肽切割的 γENaC 仅在蛋白尿患者的组织中始终被检测到,并在集合管中观察到。总之,人肾脏 γENaC 受到蛋白水解切割的影响,产生与弗林切割兼容的片段,蛋白尿与假定的前列腺素原/激肽切割位点的切割和 γENaC 内抑制性片段的去除有关。